Przydatność oznaczania stężenia prokalcytoniny w porównaniu ze stężeniem białka C-reaktywnego oraz ilością białych krwinek we krwi noworodków w monitorowaniu leczenia uogólnionych zakażeń szpitalnych

ARTYKUŁ PRZEGLĄDOWY

Przydatność oznaczania stężenia prokalcytoniny w porównaniu ze stężeniem białka C-reaktywnego oraz ilością białych krwinek we krwi noworodków w monitorowaniu leczenia uogólnionych zakażeń szpitalnych

Agnieszka Kordek 1 , Beata Łoniewska 1 , Wojciech Podraza 2 , Tomasz Nikodemski 3 , Jacek Rudnicki 1

1. Klinika Patologii Noworodka Pomorskiego Uniwersytetu Medycznego w Szczecinie
2. Katedra i Zakład Fizyki Medycznej Pomorskiego Uniwersytetu Medycznego w Szczecinie
3. Oddział Anestezjologii, Reanimacji i Intensywnej Terapii z Pododdziałem Ostrych Zatruć Samodzielnego Publicznego Szpitala Klinicznego Nr 2 w Szczecinie

Opublikowany: 2014-12-21
DOI: 10.5604/17322693.1133101
GICID: 01.3001.0003.1392
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2014; 68 : 1516-1523

 

Abstrakt

Przypisy

  • 1. Adams-Chapman I., Stoll B.J.: Prevention of nosocomial infectionsin the neonatal intensive care unit. Curr. Opin. Pediatr., 2002;14: 157-164
    Google Scholar
  • 2. Ali M.A., Moaz M.A., Ghoniem E., Abd El Motaleb T., Sheri N.: Reliabilityof serum procalcitonin concentrations for the diagnosis ofsepsis in neonates. Egypt. J. Immunol., 2008; 15: 75-84
    Google Scholar
  • 3. Auriti C., Fiscarelli E., Ronchetti M.P., Argentieri M., MarroccoG., Quondamcarlo A., Seganti G., Bagnoli F., Buonocore G., Serra G.,Bacolla G., Mastropasqua S., Mari A., Corchia C., Prencipe G. et al.:Procalcitonin in detecting neonatal nosocomial sepsis. Arch. Dis.Child Fetal Neonatal Ed., 2012; 97: F368-F370
    Google Scholar
  • 4. Blommendahl J., Janas M., Laine S., Miettinen A., Ashorn P.: Comparisonof procalcitonin with CRP and differential white blood cellcount for diagnosis of culture-proven neonatal sepsis. Scand. J. Infect.Dis., 2002; 34: 620-622
    Google Scholar
  • 5. Chiesa C., Pacifico L., Rossi N., Panerto A., Matrunola M., MancusoG.: Procalcitonin as a marker of nosocomial infections in the neonatalintensive care unit. Intensive Care Med., 2000; 26: S175-S177
    Google Scholar
  • 6. Chirico G., Loda C.: Laboratory aid to the diagnosis and therapyof infection in the neonate. Pediatr. Rep., 2011; 3: e1
    Google Scholar
  • 7. Enguix A., Rey C., Concha A., Medina A., Coto D., Dieguez M.A.:Comparison of procalcitonin with C-reactive protein ans serum amyloidfor the early diagnosis of bacterial sepsis in critically ill neonatesand children. Intensive Care Med., 2001; 27: 211-215
    Google Scholar
  • 8. Escobar G.J.: Effect of the systemic inflammatory response onbiochemical markers of neonatal bacterial infection: A fresh lookat old confounders. Clin. Chem., 2003; 49: 21-22
    Google Scholar
  • 9. Fendler W.M., Piotrowski A.J.: Procalcitonin in the early diagnosisof nosocomial sepsis in preterm neonates. J. Paediatr. Child Health,2008; 44: 114-118
    Google Scholar
  • 10. Goldstein B., Giroir B., Randolph A.: International Pediatric SepsisConsensus Conference: Definitions for sepsis and organ dysfunctionin pediatrics. Pediatr. Crit. Care Med., 2005; 6: 2-8
    Google Scholar
  • 11. Gomella T.L.: Neonatology. The McGraw-Hill Companies, Inc.,Lange Medical Books/McGraw-Hill International, New York 2013
    Google Scholar
  • 12. Guibourdenche J., Bedu A., Petzold L., Marchand M., Mariani–Kurdijan P., Hurtaud-Roux M.F., Aujard Y., Porquet D.: Biochemicalmarkers of neonatal sepsis: value of procalcitonin in the emergencysetting. Ann. Clin. Biochem., 2002; 39: 130-135
    Google Scholar
  • 13. Kordek A.: Concentrations of procalcitonin and C-reactive protein,white blood cell count, and the immature-to-total neutrophilratio in the blood of neonates with nosocomial infections: Gram–negative bacilli vs coagulase-negative staphylococci. Eur. J. Clin.Microbiol. Infect. Dis., 2011; 30: 455-457
    Google Scholar
  • 14. López Sastre J.B., Pérez Solís D., Roqués Serradilla V., FernándezColomer B., Coto Cotallo G.D., Krauel Vidal X., Narbona LópezE., Garcia del Rio M., Sánchez Luna M., Belaustequi Cueto A., MoroSerrano M., Urbón Artero A., Alvaro Iglesias E., Cotero Lavin A., Martinez Vilalta E. et al.: Procalcitonin is not sufficiently reliable tobe the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr.,2006; 6: 16
    Google Scholar
  • 15. Meisner M.: Procalcitonin. A new, innovative infection parameter.Biochemical and clinical aspect., Georg Thieme Verlag, Stuttgart,New York, 2000: 162-181
    Google Scholar
  • 16. Meisner M., Tschaikowsky K., Palmaers T., Schmidt T.: Comparisonof procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrationsat different SOFA scores during the course of sepsis andMODS. Crit. Care, 1999; 3: 45-50
    Google Scholar
  • 17. Nylen E.S., Whang K.T., Snider R.H.Jr., Steinwald P.M., White J.C.,Becker K.L.: Mortality is increased by procalcitonin and decreased byan antiserum reactive to procalcitonin in experimental sepsis. Crit.Care Med., 1998; 26: 1001-1006
    Google Scholar
  • 18. Polin R.A., Randis T.M.: Biomarkers for late-onset neonatal sepsis.Genome Med., 2010; 2: 58
    Google Scholar
  • 19. Polin R.A., Saiman L.: Nosocomial infections in the neonatal intensivecare unit. NeoReviews, 2003; 4: 81-89
    Google Scholar
  • 20. Powel K.R., Marcy M.S.: Laboratory aids for diagnosis of neonatalsepsis. In: Remington J.S., Klein J.O.(ed.). Infectious diseases of thefetus and newborn infant. Philadelphia Pennsylvania: W.B. SaundersCo.; 1995: 1223-1240
    Google Scholar
  • 21. Reinhart K., Karzai W., Meisner M.: Procalcitonin as a markerof the systemic inflammatory response to infection. Intensive CareMed., 2000; 26: 1193-1200
    Google Scholar
  • 22. Rossum A., Wulkan R., Oudesluys-Murphy A.: Procalcitonin asan early marker of infection in neonates and children. Lancet Infect.Dis., 2004; 4: 620-630
    Google Scholar
  • 23. Schelonka R.L., Chai M.K., Yoder B.A., Hensley D., Brockett R.M.,Ascher D.P.: Volume of blood required to detect common neonatalpathogens. J. Pediatr., 1996; 129: 275-278
    Google Scholar
  • 24. Stocker M., Fontana M., El Helou S., Wegscheider K., Berger T.M.:Use of procalcitonin-guided decision-making to shorten antibiotictherapy in suspected neonatal early-onset sepsis: prospective randomizedintervention trial. Neonatology, 2010; 97: 165-174
    Google Scholar
  • 25. Stockwell J.A.: Nosocomial infections in the pediatric intensivecare unit: Affecting the impact on safety and outcome. Pediatr. Crit.Care Med., 2007; 8: S21-S37
    Google Scholar
  • 26. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., EhrenkranzR.A., Lemons J.A., Donovan E.F., Stark A.R., Tyson J.E., OhW., Bauer C.R., Korones S.B., Shankaran S., Laptook A.R. et al.: Late-onsetsepsis in very-low-birth-weight neonates: the experienceof the National Institute of Child Health and Human DevelopmentNeonatal Research Network. Pediatrics, 2002; 110: 285-291
    Google Scholar
  • 27. Töllner U.: Early diagnosis of septicemia in the newborn. Clinicalstudies and sepsis score. Eur. J. Pediatr., 1982; 138: 331-337
    Google Scholar
  • 28. Vazzalwar R., Pina-Rodrigues E., Puppala B.L., Angst D.B., SchweigL.: Procalcitonin as a screening test for late-onset sepsis in pretermvery low birth weight infants. J. Perinatol., 2005; 25: 397-402
    Google Scholar
  • 29. Yu Z., Liu J., Sun Q., Qiu Y., Han S., Guo X.: The accuracy of theprocalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis.Scand. J. Infect. Dis., 2010; 42: 723-733
    Google Scholar
  • 30. Zahedpasha Y., Ahmadpour-Kacho M., Hajiahmadi M., HaghshenasM.: Procalcitonin as a marker of neonatal sepsis. Iran. J. Pediatr.,2009; 19: 117-122
    Google Scholar

Pełna treść artykułu

Przejdź do treści